Policy paper

Drug strategy annual review: 2012 to 2013

The second annual review of the drug strategy, 'Delivering within a new landscape', updates progress on the 3 strands of the strategy since May 2012.

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Documents

Drug strategy annual review: delivering within a new landscape

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Drug strategy 2010: evaluation framework

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The drug strategy’s second annual review highlights the actions taken and the priorities for the year ahead on reducing demand, restricting supply and building recovery. Case studies are also provided.

Accompanying the review is the evaluation framework. The framework was developed to assess the drug strategy’s effectiveness and value for money. This document outlines the evaluation stages, the approach to evaluation and the next steps.

Updates to this page

Published 12 December 2013

Sign up for emails or print this page